Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 52.97%12.71B | 19.71%36.68B | 33.55%8.31B | -10.96%30.64B | -24.91%7.79B | 4.75%7.79B | 6.76%8.85B | -25.26%6.22B | -1.52%34.42B | 25.87%10.37B |
| Cost of revenue | 67.78%10.41B | 21.34%29.23B | 38.29%6.21B | 1.20%24.09B | -6.22%6.28B | 24.87%6.51B | 12.85%6.81B | -23.38%4.49B | -10.14%23.8B | -5.65%6.7B |
| Gross profit | 9.27%2.3B | 13.73%7.45B | 21.35%2.1B | -38.24%6.55B | -59.06%1.5B | -42.36%1.28B | -9.56%2.04B | -29.72%1.73B | 25.50%10.61B | 222.98%3.67B |
| Operating expense | 12.44%1.3B | 17.26%4.91B | 13.75%1.16B | 11.67%4.18B | 13.47%1.21B | 9.54%976M | 15.09%984M | 8.53%1.02B | 13.21%3.75B | 22.92%1.06B |
| Operating profit | 5.40%996M | 7.51%2.55B | 32.17%945M | -65.48%2.37B | -88.61%297M | -77.00%307M | -24.66%1.05B | -53.21%715M | 33.40%6.87B | 858.46%2.61B |
| Net non-operating interest income (expenses) | -56.38%-380M | -48.51%-1.2B | 20.59%-243M | -7.16%-808M | 32.28%-128M | -4.66%-202M | 8.02%-172M | -65.41%-306M | 2.46%-754M | -2.72%-189M |
| Non-operating interest income | 550.00%39M | 450.00%33M | 500.00%6M | 100.00%6M | 100.00%2M | 200.00%3M | --0 | 0.00%1M | -40.00%3M | 0.00%1M |
| Non-operating interest expense | 68.27%419M | 63.75%1.23B | 39.89%249M | -0.53%753M | 10.53%210M | -0.52%193M | -8.02%172M | -4.30%178M | -2.70%757M | 2.70%190M |
| Total other finance cost | ---- | ---- | ---- | --61M | ---80M | --12M | --0 | --129M | ---- | ---- |
| Net investment income | 97.45%-4M | -182.61%-190M | -660.71%-157M | 152.75%230M | 2,450.00%153M | 134.04%110M | -5.17%-61M | -70.83%28M | -38.93%91M | -91.67%6M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 82.54%-22M | -132.43%-1.83B | -227.27%-126M | 5.64B | 3.32B | 2.08B | 138M | 99M | 0 | 0 |
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 331.31%854M | 367M | 371.23%198M | 363.01%192M | 6M | 0 | 0 | 77.33%-73M | -73M |
| Income from associates and other participating interests | -128.85%-15M | -489.47%-444M | 92.59%52M | 522.22%114M | 6,500.00%66M | 221.74%28M | -40.00%-7M | 27M | -139.71%-27M | -98.11%1M |
| Special income (charges) | -96.92%4M | 104.65%181M | 130M | -785.00%-3.89B | -12,933.33%-3.91B | 0 | 60.00%16M | 0 | -360.36%-440M | -129.13%-30M |
| Less:Restructuring and mergern&acquisition | --0 | ---179M | ---179M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -108.16%-4M | 95.56%-2M | --49M | -110.23%-45M | -196.67%-29M | --0 | ---- | ---- | 360.36%440M | 129.13%30M |
| Less:Write off | ---- | --0 | ---- | --3.94B | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 97.06%-1M | 202.34%131M | 50.72%-34M | 58.58%-128M | 93.50%-40M | -104.66%-18M | 99.06%-1M | -365.38%-69M | -143.31%-309M | -480.19%-615M |
| Income before tax | -38.42%577M | -98.63%51M | 88.15%937M | -30.46%3.72B | -102.93%-50M | 102.01%2.31B | -8.40%960M | -65.73%498M | 24.15%5.35B | 1,622.32%1.71B |
| Income tax | 133.78%519M | -111.07%-265M | 41.40%222M | 53.76%2.39B | 177.86%1.14B | 123.56%740M | 6.29%355M | -67.36%157M | 0.45%1.56B | 1,270.00%411M |
| Net income | -91.89%58M | -76.09%317M | 110.29%715M | -65.05%1.33B | -192.12%-1.19B | 92.88%1.57B | -15.13%606M | -64.98%340M | 37.51%3.79B | 1,011.27%1.29B |
| Net income continuous operations | -91.89%58M | -76.19%316M | 109.68%715M | -65.02%1.33B | -192.12%-1.19B | 93.24%1.57B | -15.27%605M | -64.92%341M | 37.46%3.79B | 1,011.27%1.29B |
| Noncontrolling interests | 10.00%33M | -20.57%112M | -46.43%30M | -29.85%141M | -27.59%21M | -14.89%40M | -60.00%24M | -13.85%56M | 214.06%201M | 314.29%29M |
| Net income attributable to the company | -96.35%25M | -82.78%204M | 141.70%684M | -67.01%1.19B | -195.89%-1.21B | 99.87%1.53B | -11.15%582M | -68.73%283M | 33.28%3.59B | 954.73%1.27B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -96.35%25M | -82.78%204M | 141.70%684M | -67.01%1.19B | -195.89%-1.21B | 99.87%1.53B | -11.15%582M | -68.73%283M | 33.28%3.59B | 954.73%1.27B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -96.29%0.36 | -82.70%2.91 | 141.30%9.7002 | -67.05%16.82 | -195.77%-17.21 | 99.45%21.74 | -11.08%8.27 | -68.79%4.02 | -33.86%51.05 | 516.94%17.97 |
| Diluted earnings per share | -96.29%0.36 | -82.74%2.9 | 141.90%9.7002 | -66.98%16.8 | -195.77%-17.21 | 99.17%21.71 | -11.18%8.26 | -68.75%4.01 | -33.22%50.88 | 516.94%17.97 |
| Dividend per share | 0 | -68.00%5.12 | 0 | -38.46%16 | -38.46%16 | 0 | 0 | 0 | 23.81%26 | 23.81%26 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |